Update file Feedback.tsx

src/contents/Human Practices/Feedback.tsx

 
-import { HowOftenTreatmentatients, MoreInfoOnTherapyBoth, OpenToGeneTherapyatients,MostStressfulForRelativeatients } from '../../components/Graph';
+import * as Graph from '../../components/Graph';
 import { H4 } from '../../components/Headings';
 import { CollapsibleInfoBox } from "../../components/Collapsible";
 
@@ -12,15 +12,15 @@ export function HPFeedback(){
             
             <div className="row align-items-center">
                 <div className="col">
-                    <HowOftenTreatmentatients/>
+                    <Graph.HowOftenTreatmentatients/>
                     <p>The majority of respondents (62.70%) indicated that they or their relative require medical treatment or therapy daily. Weekly treatment was necessary for 14.59%, while 9.73% needed therapy several times per week. Only 6.49% reported needing treatment either monthly or rarely. The high frequency of daily treatments highlights the heavy burden of managing cystic fibrosis and reinforces the potential appeal of gene therapy, which could reduce the need for constant medical intervention. </p>
                 </div>
                 <div className="col">
-                    <OpenToGeneTherapyatients/>
+                    <Graph.OpenToGeneTherapyatients/>
                     <p>A significant majority, 78.72%, indicated that they would be open to gene therapy if it significantly improved symptoms, while only 1.42% said no. This overwhelming support aligns with the hope patients have for less invasive and more effective treatments. This also reflects the possibility of gene therapy becoming a central treatment method, especially given the heavy therapeutic load CF patients already carry.</p>
                 </div>
                 <div className="col"> 
-                    <MoreInfoOnTherapyBoth/>
+                    <Graph.MoreInfoOnTherapyBoth/>
                     <p>A vast majority, 93.48%, expressed interest in more information about gene therapy. This mirrors the general public’s desire for further education and suggests that while there is strong support for gene therapy, people still feel they lack sufficient knowledge to make fully informed decisions. Patients especially emphasized the importance of safety and long-term efficacy, areas that should be focal points in future communications. </p>
                 </div>
             </div>
@@ -32,13 +32,20 @@ export function HPFeedback(){
             </div>
             <div>
                 <CollapsibleInfoBox id="collapsible1" open={false} title="See the full results of our surveys">
-                    test
-                </CollapsibleInfoBox>
-                <CollapsibleInfoBox id="collapsible2" open={true} title="See the full results of our surveys">
-                    <div>
-                        <MostStressfulForRelativeatients/>
-                        <p>test</p>
+                    <div className="row align-items-center">
+                        <div className="col">
+                            <div>
+                            <Graph.WhoAffectedatients/>
+                            </div>
+                            <div>
+                                <Graph.HeardOfCFPublic/>
+                            </div>
+                            <div>
+                                <Graph.HowDidYouLearnPublic/>
+                            </div>
+                        </div>
                     </div>
+                    
                 </CollapsibleInfoBox>
             </div>
         </div>